The hope is that someday doctors will be able to identify men who have a fast moving aggressive form of the disease. Such a test could also help lead to the development of new therapies.
Researchers say metabolites have been underappreciated relative to genes being profiled in cancer and that this approach could be extended to other cancers.
However, before a urine test involving metabolites could become standard, it would have to undergo clinical trials.
